1887

oa SA Pharmaceutical Journal - New product focus : drug info

Volume 77, Issue 7
  • ISSN : 2221-5875

 

Abstract

Telmisartan is approved for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents, including a fixed-dose combination with hydrochlorothiazide.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_sapj/77/7/EJC82433
2010-08-01
2017-03-26

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error